Skip to content

Author

M. Roest

We have 3 of 46 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

ADAMTS13 fusion constructs with dual activity against VWF: a novel strategy for iTTP.

BACKGROUND Immune thrombotic thrombocytopenic purpura (iTTP) is a life-threatening thrombotic microangiopathy. iTTP pathophysiology is based on severe ADAMTS13 deficiency caused by autoantibodies, leading to accumulation of ultra-large von Willebrand factor (VWF) multimers and microvascular thrombosis. Engineered ADAMT...

Yun-Peng Xue, M. Roest, S. J. Humphreys et al. · 1 citation
#protein folding Open access Oct 2026

Short-Term Dietary Exposures and Thrombin Generation in Tanzanian Men: Exploratory Coagulation-Focused Analysis of a Randomized Dietary-Switch Trial.

BACKGROUND Rapid dietary transitions in sub-Saharan Africa may alter coagulation profiles; however, this remains poorly characterized. METHODS An open-label dietary-intervention trial in Tanzania enrolled 77 healthy men aged 20 to 40 years. They underwent 1 of 3 interventions (n=22 per arm): heritage-to-Western-style...

Eka Patricia Kisali, M. Roest, T. Pecht et al. · 0 citations
Open access Sep 2026

Thrombin dynamics and clinical events in cirrhosis: low prothrombin conversion predicts bleeding risk

Pro- and anti-coagulant factors are significantly altered in liver cirrhosis resulting in an increased bleeding and thrombosis risk. The thrombin generation (TG) test often seems unaltered in cirrhosis, indicating that a new hemostatic balance is reached. TG is determined by prothrombin conversion and thrombin inactiva...

R. Willems, A. Zanetto, E. Campello et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.